Skinvisible (SKVI) Total Current Liabilities (2010 - 2026)

Skinvisible (SKVI) has 17 years of Total Current Liabilities data on file, last reported at $5.3 million in Q1 2026.

• For the quarter ending Q1 2026, Total Current Liabilities rose 23.96% year-over-year to $5.3 million; the trailing twelve-month figure through Mar 2026 stood at $5.3 million (up 23.96% YoY), and the FY2025 full-year result was $5.0 million, up 37.2% from the prior year.
• Total Current Liabilities improved to $5.3 million in Q1 2026, from $5.0 million in the prior quarter.
• In the past five years, Total Current Liabilities ranged from a high of $5.3 million in Q1 2026 to a low of $2.7 million in Q1 2023.
• A 5-year average of $3.9 million and a median of $3.7 million in 2024 frame the typical range for Total Current Liabilities.
• Across the five-year window, Total Current Liabilities dropped 12.62% in 2023 and surged 50.18% in 2024, its largest moves.
• Tracing SKVI's Total Current Liabilities over 5 years: stood at $3.6 million in 2022, then fell by 3.64% to $3.5 million in 2023, then gained by 4.12% to $3.7 million in 2024, then surged by 37.2% to $5.0 million in 2025, then advanced by 5.16% to $5.3 million in 2026.
• Business Quant data shows SKVI's Total Current Liabilities at $5.3 million in Q1 2026, $5.0 million in Q4 2025, and $4.8 million in Q3 2025.